ID G2LTK5_9XANT Unreviewed; 980 AA. AC G2LTK5; DT 16-NOV-2011, integrated into UniProtKB/TrEMBL. DT 16-NOV-2011, sequence version 1. DT 25-OCT-2017, entry version 48. DE RecName: Full=Valine--tRNA ligase {ECO:0000256|HAMAP-Rule:MF_02004}; DE EC=6.1.1.9 {ECO:0000256|HAMAP-Rule:MF_02004}; DE AltName: Full=Valyl-tRNA synthetase {ECO:0000256|HAMAP-Rule:MF_02004}; DE Short=ValRS {ECO:0000256|HAMAP-Rule:MF_02004}; GN Name=valS {ECO:0000256|HAMAP-Rule:MF_02004, GN ECO:0000313|EMBL:AEO43700.1}; GN ORFNames=XACM_3453 {ECO:0000313|EMBL:AEO43700.1}; OS Xanthomonas axonopodis pv. citrumelo F1. OC Bacteria; Proteobacteria; Gammaproteobacteria; Xanthomonadales; OC Xanthomonadaceae; Xanthomonas. OX NCBI_TaxID=981368 {ECO:0000313|EMBL:AEO43700.1, ECO:0000313|Proteomes:UP000001276}; RN [1] {ECO:0000313|EMBL:AEO43700.1, ECO:0000313|Proteomes:UP000001276} RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=F1 {ECO:0000313|EMBL:AEO43700.1}; RX PubMed=21908674; DOI=10.1128/JB.05777-11; RA Jalan N., Aritua V., Kumar D., Yu F., Jones J.B., Graham J.H., RA Setubal J.C., Wang N.; RT "Comparative Genomic Analysis of Xanthomonas axonopodis pv. citrumelo RT F1, Which Causes Citrus Bacterial Spot Disease, and Related Strains RT Provides Insights into Virulence and Host Specificity."; RL J. Bacteriol. 193:6342-6357(2011). CC -!- FUNCTION: Catalyzes the attachment of valine to tRNA(Val). As CC ValRS can inadvertently accommodate and process structurally CC similar amino acids such as threonine, to avoid such errors, it CC has a "posttransfer" editing activity that hydrolyzes mischarged CC Thr-tRNA(Val) in a tRNA-dependent manner. {ECO:0000256|HAMAP- CC Rule:MF_02004, ECO:0000256|SAAS:SAAS00870405}. CC -!- CATALYTIC ACTIVITY: ATP + L-valine + tRNA(Val) = AMP + diphosphate CC + L-valyl-tRNA(Val). {ECO:0000256|HAMAP-Rule:MF_02004, CC ECO:0000256|SAAS:SAAS00711221}. CC -!- SUBUNIT: Monomer. {ECO:0000256|HAMAP-Rule:MF_02004, CC ECO:0000256|SAAS:SAAS00870389}. CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000256|HAMAP-Rule:MF_02004, CC ECO:0000256|SAAS:SAAS00889155}. CC -!- DOMAIN: The C-terminal coiled-coil domain is crucial for CC aminoacylation activity. {ECO:0000256|HAMAP-Rule:MF_02004}. CC -!- DOMAIN: ValRS has two distinct active sites: one for CC aminoacylation and one for editing. The misactivated threonine is CC translocated from the active site to the editing site. CC {ECO:0000256|HAMAP-Rule:MF_02004}. CC -!- SIMILARITY: Belongs to the class-I aminoacyl-tRNA synthetase CC family. ValS type 1 subfamily. {ECO:0000256|HAMAP-Rule:MF_02004, CC ECO:0000256|SAAS:SAAS00870396}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; CP002914; AEO43700.1; -; Genomic_DNA. DR RefSeq; WP_014091065.1; NC_016010.1. DR EnsemblBacteria; AEO43700; AEO43700; XACM_3453. DR KEGG; xax:XACM_3453; -. DR KO; K01873; -. DR OrthoDB; POG091H01HY; -. DR Proteomes; UP000001276; Chromosome. DR GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell. DR GO; GO:0002161; F:aminoacyl-tRNA editing activity; IEA:InterPro. DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-UniRule. DR GO; GO:0004832; F:valine-tRNA ligase activity; IEA:UniProtKB-UniRule. DR GO; GO:0006438; P:valyl-tRNA aminoacylation; IEA:UniProtKB-UniRule. DR CDD; cd07962; Anticodon_Ia_Val; 1. DR Gene3D; 1.10.287.380; -; 1. DR Gene3D; 1.10.730.10; -; 1. DR Gene3D; 3.40.50.620; -; 1. DR HAMAP; MF_02004; Val_tRNA_synth_type1; 1. DR InterPro; IPR001412; aa-tRNA-synth_I_CS. DR InterPro; IPR002300; aa-tRNA-synth_Ia. DR InterPro; IPR033705; Anticodon_Ia_Val. DR InterPro; IPR013155; M/V/L/I-tRNA-synth_anticd-bd. DR InterPro; IPR014729; Rossmann-like_a/b/a_fold. DR InterPro; IPR010978; tRNA-bd_arm. DR InterPro; IPR009080; tRNAsynth_Ia_anticodon-bd. DR InterPro; IPR037118; Val-tRNA_synth_C_sf. DR InterPro; IPR019499; Val-tRNA_synth_tRNA-bd. DR InterPro; IPR009008; Val/Leu/Ile-tRNA-synth_edit. DR InterPro; IPR002303; Valyl-tRNA_ligase. DR Pfam; PF08264; Anticodon_1; 1. DR Pfam; PF00133; tRNA-synt_1; 1. DR Pfam; PF10458; Val_tRNA-synt_C; 1. DR PRINTS; PR00986; TRNASYNTHVAL. DR SUPFAM; SSF46589; SSF46589; 1. DR SUPFAM; SSF47323; SSF47323; 1. DR SUPFAM; SSF50677; SSF50677; 2. DR TIGRFAMs; TIGR00422; valS; 1. DR PROSITE; PS00178; AA_TRNA_LIGASE_I; 1. PE 3: Inferred from homology; KW Aminoacyl-tRNA synthetase {ECO:0000256|HAMAP-Rule:MF_02004, KW ECO:0000256|RuleBase:RU363035, ECO:0000256|SAAS:SAAS00711227, KW ECO:0000313|EMBL:AEO43700.1}; KW ATP-binding {ECO:0000256|HAMAP-Rule:MF_02004, KW ECO:0000256|RuleBase:RU363035, ECO:0000256|SAAS:SAAS00711241}; KW Coiled coil {ECO:0000256|HAMAP-Rule:MF_02004, KW ECO:0000256|SAAS:SAAS00870403}; KW Complete proteome {ECO:0000313|Proteomes:UP000001276}; KW Cytoplasm {ECO:0000256|HAMAP-Rule:MF_02004, KW ECO:0000256|SAAS:SAAS00889138}; KW Ligase {ECO:0000256|HAMAP-Rule:MF_02004, KW ECO:0000256|RuleBase:RU363035, ECO:0000256|SAAS:SAAS00711254}; KW Nucleotide-binding {ECO:0000256|HAMAP-Rule:MF_02004, KW ECO:0000256|RuleBase:RU363035, ECO:0000256|SAAS:SAAS00711287}; KW Protein biosynthesis {ECO:0000256|HAMAP-Rule:MF_02004, KW ECO:0000256|RuleBase:RU363035, ECO:0000256|SAAS:SAAS00711230}. FT DOMAIN 17 663 tRNA-synt_1. {ECO:0000259|Pfam:PF00133}. FT DOMAIN 704 856 Anticodon_1. {ECO:0000259|Pfam:PF08264}. FT DOMAIN 916 979 Val_tRNA-synt_C. {ECO:0000259|Pfam: FT PF10458}. FT COILED 914 941 {ECO:0000256|HAMAP-Rule:MF_02004}. FT MOTIF 43 53 "HIGH" region. {ECO:0000256|HAMAP-Rule: FT MF_02004}. FT MOTIF 586 590 "KMSKS" region. {ECO:0000256|HAMAP-Rule: FT MF_02004}. FT BINDING 589 589 ATP. {ECO:0000256|HAMAP-Rule:MF_02004}. SQ SEQUENCE 980 AA; 110981 MW; 020053D53036EF86 CRC64; MTTLASSYDP SSFESRLYAQ WEAAGYFVPS GKGEPYTVLL PPPNVTGTLH MGHAFQQTLM DALVRYHRMR GYDTLWQVGT DHAGIATEMV VSRNLALEGK GQTRDSLGRE GFIAKVWEWK AESGDTIERQ MRRLGTSSDW SRSTFTMDPQ PSAAVNEAFV RWYEQGLIYR GQRLVNWDPV LKTAISDLEV ENVEEDGFLW SIRYPLADGV SYEHVEHDAD GNETLRETRD YLVVATTRPE TMLGDTAVMV HPEDARYLTL HDARIVLPLT GRQVPVITDD YVDRAFGTGV VKVTPAHDFN DYQVGERHNL PLVNLFTVDA KIIDPREQYP DDEYPVVDQG IDWRELNQVQ RRRTGQHFAY SIPSAYVGLD RYEARKLVLA HLEDEGRLVE TKPHKLQVPR GDRTGQVIEP YLTDQWFVKM DALAKRGLEL VESGQIKFVP PNWINTYRHW MENIQDWCIS RQLWWGHRIP AWFDEAGKCY VGHDEAQVRA KHGLGAEIAL HQDSDVLETW FSSQLWPFST LGWPDAQAMA ERGFARYLPS SVLVTGFDII FFWVARMIMA TDSFTGQVPF RDVYITGLIR DAQGQKMSKS KGNVLDPLDI IDGISIEDLV AKRTHGLMQP RMAEKIEKAT RKEFPDGIIA HGADALRFTI AALATHGRDI KFDLGRAEGY KNFCNKLWNA TRFVLMNTEG ARFTGVPQPR TEAEKWILAR LDKATAETHA HYANYRFDLL AQSLYEFAWN AFCDWFVELA KPALNNQDAD AAASTRHTLL YVLESLLRLL HPLTPFVTEE LWQQVAPRLG ITTATISLQS FPQPGDVDTS SYATAEADVE WLKSMVSALR RVRSELNVPP SKQVRLLLQA GTADDRPRVA RFASQLSFLL KLERIDWLDA GQDTPPSAAA IVGELTLLVP LEGLVDMDAE RTRLDKEIKR VEGEIAKCNG KLGSATFVQN APAAVVEQER ARLNDWTTQL TGLREQRAKI //